Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
| Data(s) |
23/03/2002
|
|---|---|
| Identificador |
http://www.scopus.com/inward/record.url?scp=0037160968&partnerID=8YFLogxK |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Dahlof , B , Devereau , R B , Kjeldsen , S E , Julius , S & Johnston , D 2002 , ' Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol ' The Lancet , vol 359 , no. 9311 , pp. 995-1003 . |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700 #Medicine(all) |
| Tipo |
article |
